Details for New Drug Application (NDA): 208412
✉ Email this page to a colleague
The generic ingredient in PREDNISONE is prednisone. There are sixteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the prednisone profile page.
Summary for 208412
Tradename: | PREDNISONE |
Applicant: | Strides Pharma |
Ingredient: | prednisone |
Patents: | 0 |
Pharmacology for NDA: 208412
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 208412
Suppliers and Packaging for NDA: 208412
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PREDNISONE | prednisone | TABLET;ORAL | 208412 | ANDA | QPharma Inc | 42708-166 | 42708-166-21 | 21 TABLET in 1 BOTTLE, PLASTIC (42708-166-21) |
PREDNISONE | prednisone | TABLET;ORAL | 208412 | ANDA | Medsource Pharmaceuticals | 45865-884 | 45865-884-21 | 21 TABLET in 1 BOTTLE (45865-884-21) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Feb 11, 2021 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Feb 11, 2021 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Jan 11, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription